Drug Profile
Recombinant thrombomodulin - PAION
Alternative Names: SolulinLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Berlex Biosciences
- Developer PAION
- Class Anti-inflammatories; Anticoagulants; Peptides; Platelet membrane glycoproteins; Recombinant proteins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Haemophilia; Stroke; Thrombosis
Most Recent Events
- 11 Feb 2015 Suspended - Phase-I for Haemophilia (Adjunctive treatment) in Germany (IV) prior to February 2015
- 11 Feb 2015 Suspended - Phase-I for Stroke (In volunteers) in Germany (IV) prior to February 2015
- 11 Feb 2015 Suspended - Phase-I for Thrombosis (In volunteers) in Germany (IV) prior to February 2015